United States Approves First At-Home Device for Treating Depression
The United States Food and Drug Administration (FDA) has approved the country’s first at-home medical device for treating depression, marking a significant shift in mental health care delivery. Developed by Flow Neuroscience, the prescription headset—named FL-100—allows adults with moderate to severe depression to receive treatment outside traditional clinical settings. The device is expected to enter the US market by mid-2026.
Month: Current Affairs - December 13, 2025
Category: Mental Health Policy